Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

被引：0
|
作者：
Yanwen Yao
Dongmei Yuan
Hongbing Liu
Xiaoling Gu
Yong Song
机构：
[1] Jinling Hospital,Department of Respiratory Medicine
[2] Nanjing University School of Medicine,undefined
来源：
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词：
Neutrophil to lymphocyte ratio; Prognostic factor; Tumor-related inflammation; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 479
页数：8
相关论文
共 50 条
  • [11] Safety Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Platinum-Based Regimens in the US
    Kim, Jong Seok
    Chen, Lei
    Antonio, Belen San
    Zhu, Yajun Emily
    Mitche, Lucy
    John, William
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S318 - S318
  • [12] Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy
    Yuan, Chengliang
    Huang, Meifang
    Wang, Huilin
    Jiang, Wei
    Su, Cuiyun
    Zhou, Shaozhang
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 377 - 386
  • [13] XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy
    Zou, H. Z.
    Zhao, Y. Q.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 500 - 506
  • [14] Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Wang, Ying
    Liu, Ping
    Xu, Yan
    Zhang, Weihao
    Tong, Lina
    Guo, Zhi
    Ni, Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 255 - 262
  • [15] Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Ying Wang
    Ping Liu
    Yan Xu
    Weihao Zhang
    Lina Tong
    Zhi Guo
    Hong Ni
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 255 - 262
  • [16] Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival
    Sirohi, Bhawna
    Ashley, Sue
    Norton, Alison
    Popat, Sanjay
    Hughes, Sarah
    Papadopoulos, Panagiotous
    Priest, Kathryn
    O'Brien, Mary
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : 735 - 740
  • [17] Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
    Ying, Jun
    Zhou, Danfei
    Gu, Tongjie
    Huang, Jianda
    Liu, Haijian
    BMC CANCER, 2019, 19 (1)
  • [18] Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
    Jun Ying
    Danfei Zhou
    Tongjie Gu
    Jianda Huang
    Haijian Liu
    BMC Cancer, 19
  • [19] Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer
    Zhang, Tao
    Zhang, Dong-ming
    Zhao, Da
    Hou, Xiao-ming
    Yang, Tian-ning
    JOURNAL OF BUON, 2014, 19 (03): : 742 - 748
  • [20] Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Liu, Lu
    Zhou, Fei
    Ren, Shengxiang
    Chen, Xiaoxia
    Li, Xuefei
    Li, Wei
    Zhou, Caicun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (02) : E339 - E346
12345